Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
Postdoctoral Research Associate - Hybrid Computational-Experimental Scientist in Bacterial Drug Resp
. • Is motivated to develop new methods and biological insights in parallel. Especially Excited If You Have • Experience with bacterial genetics, functional genomics, or drug-response assays. • Familiarity
-
of metabolic pathways essential for biosynthesis and redox balance. We investigate how p53 integrates metabolic cues by functioning as both a sensor and regulator of cellular metabolism. In parallel, we seek
-
will be embedded in a closely collaborating interdisciplinary team. Please keep your eyes open for related positions advertised in parallel to this one. If you see yourself to be qualified for more than
-
interdisciplinary team. Please keep your eyes open for related positions advertised in parallel to this one. If you see yourself to be qualified for more than one of them, please re-submit your application for each
-
interdisciplinary team. Please keep your eyes open for related positions advertised in parallel to this one. If you see yourself to be qualified for more than one of them, please resubmit your application for each
-
parallel, the Institute is developing state-of-the-art methods that integrate living tissues with synthetic scaffolds to model and repair organs. These efforts converge across three interrelated programmes
-
working on related topics Participate in teaching and supervision activities, in line with the candidate's profile and interests The research activities will be hosted by the Parallel Computing and
-
aims to achieve reliable genome design and synthesis – engineering cells to have specific functions – which will be a major milestone in modern biology. A dedicated social science program will support
-
redox balance. Our studies explore how p53 integrates metabolic cues by acting as both a sensor and regulator of cellular metabolism. In parallel, we are identifying metabolic changes that promote tumor
-
an unexpected heterodimer (Nucleic Acids Res 50:3254, 2022); revealed a mechanism that expands PXR's ligand binding pocket to reduce ligand's binding affinity (Proc Natl Acad Sci U S A. 120: e2217804120, 2023